(Q40039592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

4

Carosella ED

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Nathalie Rouas-Freiss

series ordinal

5

object named as

Rouas-Freiss N

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

Menier C

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Guillard C

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

6 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

578-584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2405050

29 December 2019

exact match

0 references

cites work

Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Turning cells red: signal transduction mediated by erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Identification of an acquired JAK2 mutation in polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Activated Jak2 with the V617F point mutation promotes G1/S phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

The JAK-STAT signaling pathway: input and output integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

Secretion of sHLA-G molecules in malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

7 January 2021

HLA-G inhibits the allogeneic proliferative response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

7 January 2021

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

7 January 2021

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405050

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2405050

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18059484%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 December 2019

1025496165

0 references

1 reference